Non-invasive markers of ureteropelvic junction obstruction.
about
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developmentsUrinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplastyLabel-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney diseaseAn in-depth comparison of the male pediatric and adult urinary proteomesUrine in clinical proteomics.A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome.Chemokines as potential markers in pediatric renal diseases.Congenital ureteropelvic junction obstruction: human disease and animal models.CE-MS in biomarker discovery, validation, and clinical application.Clinical proteomics in obstetrics and neonatology.Proteomic urinary biomarker approach in renal disease: from discovery to implementation.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.The nephrologist of tomorrow: towards a kidney-omic future.Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.Urinary Proteomics Yield Pathological Insights for Ureteropelvic Junction Obstruction.The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults.Is it Always Necessary to Treat an Asymptomatic Hydronephrosis Due to Ureteropelvic Junction Obstruction?Chemokines as Potential Markers in Pediatric Renal DiseasesUrinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathiesHow to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS
P2860
Q30438814-F2EE6C4F-5988-4398-92D3-077D67019B6FQ33930517-36E491BD-ABA3-478E-857E-9B08061379D8Q34634938-53B552F9-0BDA-4EE4-9681-682A6967125DQ37162841-F150B1C8-8964-4FE3-9E7C-CF438E6E3458Q37228241-4EF44FFA-1BF7-43D7-9A95-630DD42BF725Q37230698-B92BE943-19B9-4BD8-8962-F2CAA1BAD088Q37303421-C0BE4F85-80C6-4B14-BEE1-12AE50F0B87EQ37627006-B08FBEF3-61EF-4D2C-97E4-060F6D24DD95Q37777427-0E37BF93-3A00-467F-BD6A-9D0795962077Q37833587-6322FB1E-CA72-40F3-98C9-78E5643A5215Q38176934-8D2BB69E-2547-4DE3-BF78-E86FB793DD37Q38196316-58BB3FD1-BB2E-4459-8489-2C25824D7F0DQ38340351-3004D492-F21A-46DA-B213-4FDE67B2A2D2Q38767679-DFCE3E47-CFE9-4588-8802-4F23F0D9546EQ38813024-1E665902-761C-4489-981C-EAD95E503196Q42114237-B42785A1-EA71-47CD-A22D-8A9AE35260D2Q48334562-2A52783C-6ED9-431C-AD51-52F50ED7E408Q53317443-FD9A4856-80B8-4715-B569-38EC68847711Q56774723-442831C4-4EC0-4EC6-AB4D-E607C26FF8D8Q56774931-B54A4A77-C689-4055-AAAB-BD131614E39FQ57711927-32B538C6-6137-4516-9522-B6C23B892B6D
P2860
Non-invasive markers of ureteropelvic junction obstruction.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Non-invasive markers of ureteropelvic junction obstruction.
@ast
Non-invasive markers of ureteropelvic junction obstruction.
@en
Non-invasive markers of ureteropelvic junction obstruction.
@nl
type
label
Non-invasive markers of ureteropelvic junction obstruction.
@ast
Non-invasive markers of ureteropelvic junction obstruction.
@en
Non-invasive markers of ureteropelvic junction obstruction.
@nl
prefLabel
Non-invasive markers of ureteropelvic junction obstruction.
@ast
Non-invasive markers of ureteropelvic junction obstruction.
@en
Non-invasive markers of ureteropelvic junction obstruction.
@nl
P1476
Non-invasive markers of ureteropelvic junction obstruction.
@en
P2093
Stephane Decramer
P2888
P304
P356
10.1007/S00345-007-0201-8
P577
2007-08-14T00:00:00Z
P6179
1050492056